rs16886364

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_005921.2(MAP3K1):​c.482+10462A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0592 in 152,314 control chromosomes in the GnomAD database, including 283 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.059 ( 283 hom., cov: 33)

Consequence

MAP3K1
NM_005921.2 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.0930

Publications

14 publications found
Variant links:
Genes affected
MAP3K1 (HGNC:6848): (mitogen-activated protein kinase kinase kinase 1) The protein encoded by this gene is a serine/threonine kinase and is part of some signal transduction cascades, including the ERK and JNK kinase pathways as well as the NF-kappa-B pathway. The encoded protein is activated by autophosphorylation and requires magnesium as a cofactor in phosphorylating other proteins. This protein has E3 ligase activity conferred by a plant homeodomain (PHD) in its N-terminus and phospho-kinase activity conferred by a kinase domain in its C-terminus. [provided by RefSeq, Mar 2012]
MAP3K1 Gene-Disease associations (from GenCC):
  • 46,XY sex reversal 6
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • breast cancer
    Inheritance: AD Classification: MODERATE Submitted by: G2P
  • 46,XY complete gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • 46,XY partial gonadal dysgenesis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 5-56826517-A-G is Benign according to our data. Variant chr5-56826517-A-G is described in ClinVar as Benign. ClinVar VariationId is 1599911.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.11 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005921.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP3K1
NM_005921.2
MANE Select
c.482+10462A>G
intron
N/ANP_005912.1Q13233

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MAP3K1
ENST00000399503.4
TSL:1 MANE Select
c.482+10462A>G
intron
N/AENSP00000382423.3Q13233
MAP3K1
ENST00000872825.1
c.482+10462A>G
intron
N/AENSP00000542884.1
MAP3K1
ENST00000948659.1
c.482+10462A>G
intron
N/AENSP00000618718.1

Frequencies

GnomAD3 genomes
AF:
0.0593
AC:
9021
AN:
152196
Hom.:
283
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0383
Gnomad AMI
AF:
0.0461
Gnomad AMR
AF:
0.0574
Gnomad ASJ
AF:
0.0608
Gnomad EAS
AF:
0.117
Gnomad SAS
AF:
0.0557
Gnomad FIN
AF:
0.0737
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0662
Gnomad OTH
AF:
0.0621
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0592
AC:
9022
AN:
152314
Hom.:
283
Cov.:
33
AF XY:
0.0596
AC XY:
4437
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.0383
AC:
1593
AN:
41582
American (AMR)
AF:
0.0573
AC:
877
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.0608
AC:
211
AN:
3472
East Asian (EAS)
AF:
0.118
AC:
610
AN:
5178
South Asian (SAS)
AF:
0.0551
AC:
266
AN:
4824
European-Finnish (FIN)
AF:
0.0737
AC:
782
AN:
10604
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0662
AC:
4502
AN:
68022
Other (OTH)
AF:
0.0615
AC:
130
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
435
870
1305
1740
2175
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0648
Hom.:
636
Bravo
AF:
0.0590
Asia WGS
AF:
0.0730
AC:
255
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
46,XY sex reversal 6 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.3
DANN
Benign
0.39
PhyloP100
-0.093
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16886364; hg19: chr5-56122344; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.